Neuroone Medical Technologies Corp (NMTC): Cash & Equivalents
$6.57M
As of 2025-09-30
$2.05M
As of 2026-06-30
-7.0%
3-year compound annual growth
+10.2%
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-09-30 | $6.57M | +350.0% | 2025-12-17, Balance as of period end |
| 2024-09-30 | $1.46M | -72.6% | 2025-12-17, Balance as of period end |
| 2023-09-30 | $5.32M | -34.8% | 2024-12-17, Balance as of period end |
| 2022-09-30 | $8.16M | +18.2% | 2023-12-15, Balance as of period end |
| 2021-09-30 | $6.90M | +71.0% | 2022-12-22, Balance as of period end |
| 2020-09-30 | $4.04M | n/m | 2022-05-31, Balance as of period end |
| 2019-09-30 | $260.7K | n/m | 2020-12-09, Balance as of period end |
| 2018-09-30 | $13.3K | n/a | 2019-12-20, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Neuroone Medical Technologies Corp (NMTC) | 2025-09-30 | $6.57M | +350.0% |
| InspireMD, Inc. (NSPR) | 2025-12-31 | $8.94M | -52.7% |
| WORK Medical Technology Group LTD (WOK) | 2025-09-30 | $4.09M | -37.7% |
| Beyond Air, Inc. (XAIR) | 2026-03-31 | $6.74M | +44.5% |
| Encision Inc (ECIA) | 2025-03-31 | $257.4K | +505.6% |
| Allurion Technologies, Inc. (ALUR) | 2025-12-31 | $5.41M | -64.8% |
| Cerenome, Inc. (CNSY) | 2025-12-31 | $4.26M | n/m |
| Biotricity Inc. (BTCY) | 2026-03-31 | $149.8K | -59.0% |
| Profound Medical Corp. (PROF) | 2025-12-31 | $59.72M | +8.8% |
Compare NMTC, NSPR, WOK, XAIR side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗